Clinical Trials in Colorado

Showing 4641-4660 of 18,143 trials

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

NCT03635164

This is a multi-center, prospective, single-arm phase I/Ib safety trial. Patients eligible for treatment must be diagnosed with non-metastatic, biopsy-proven stage II-IVB oral cavity, stage III-IVB larynx and hypopharynx, or stage III-IVB HPV/p16 negative intermediate-high risk oropharynx head and neck cancer, and must be eligible and amenable to surgical resection.

Squamous Cell Carcinoma of the Head and Neck

University of Colorado, Denver21 participantsStarted Nov 2018

Aurora, Colorado, United States • Colorado Springs, Colorado, United States • Fort Collins, Colorado, United States

COMPLETEDPhase 153 miles

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

This study is designed to investigate the safety and tolerability of a new drug, AZD5363, in patients with advanced cancer - and to identify a dose and schedule that can be used in the future. This study will also investigate how the body handles AZD5363 (ie, how quickly the body absorbs and removes the drug). This study will also investigate anti-tumour activity of AZD5363 in patients with advanced / metastatic breast, gynaecological cancers or other solid cancers bearing either AKT1 / PIK3CA or PTEN mutation.

Advanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more

AstraZeneca285 participantsStarted Dec 2010

Los Angeles, California, United States • Stanford, California, United States • West Hollywood, California, United States +31 more locations

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Find Trials by Condition in Colorado

Adolescent Master Protocol

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Distal Radius Interventions for Fracture Treatment

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Beacon Sensors and Telerehabilitation for Low Vision

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

LTFU for All Cell and Gene Therapy Studies

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

Cough Reduction in IPF With Nalbuphine ER